Home/Filings/4/0000914475-24-000094
4//SEC Filing

MORROW GEORGE J 4

Accession 0000914475-24-000094

CIK 0000914475other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 5:25 PM ET

Size

14.1 KB

Accession

0000914475-24-000094

Insider Transaction Report

Form 4
Period: 2024-03-14
Transactions
  • Sale

    Common Stock

    2024-03-14$139.42/sh20,000$2,788,4320 total
  • Exercise/Conversion

    Common Stock

    2024-03-14$39.79/sh+20,000$795,80020,000 total
  • Exercise/Conversion

    Common Stock

    2024-03-14$39.79/sh+20,000$795,80020,000 total
  • Sale

    Common Stock

    2024-03-14$139.41/sh20,000$2,788,2780 total
  • Exercise/Conversion

    Non-Qualified Stock Option

    2024-03-14$39.79/sh20,000$795,80020,000 total
    Exercise: $39.79Exp: 2025-09-30Common Stock (20,000 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option

    2024-03-14$39.79/sh20,000$795,8000 total
    Exercise: $39.79Exp: 2025-09-30Common Stock (20,000 underlying)
Footnotes (4)
  • [F1]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
  • [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $137.87 to $142.32. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $137.83 to $142.32. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F4]Option granted September 30, 2015 and vests in 36 equal monthly installments.

Issuer

NEUROCRINE BIOSCIENCES INC

CIK 0000914475

Entity typeother
IncorporatedNC

Related Parties

1
  • filerCIK 0001068754

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 5:25 PM ET
Size
14.1 KB